PainChek partners with Eldermark to expand US market reach
| Stock | Painchek Ltd (PCK.ASX) |
|---|---|
| Release Time | 27 May 2025, 8:50 a.m. |
| Price Sensitive | Yes |
PainChek partners with Eldermark to expand US market reach
- Reseller and integration agreement with Eldermark, a major US provider of care management systems
- Aims to drive adoption of PainChek's pain assessment technology in the US long-term care sector
- Partnership will integrate PainChek's AI-powered pain assessment tools into Eldermark's care management platform
PainChek Ltd (ASX: PCK), developer of the world's first smartphone-based pain assessment and monitoring application, has announced a reseller and integration agreement with Eldermark Software LLC, a major provider of care management systems (CMS) in the United States. This agreement, effective immediately and renewing automatically each year unless terminated, will enable Eldermark to offer PainChek's digital pain assessment solution to its extensive network of long-term care clients across the US. Eldermark has been providing dedicated senior living solutions in the US and Canada for 30 years, with more than 116,000 client users. Through this collaboration, PainChek aims to drive adoption of its innovative technology within a market increasingly focused on enhancing resident care and outcomes. The partnership will include seamless integration of PainChek's technology within Eldermark's CMS platform, providing users with real-time access to advanced pain assessment tools powered by AI and facial recognition technology. By combining PainChek's capabilities with Eldermark's robust CMS infrastructure, the partnership seeks to improve the accuracy of pain management, reduce caregiver burden, and enhance quality of life for residents. Under the terms of the agreement, Eldermark will act as a non-exclusive reseller of PainChek's Adult solution, targeting the US long-term care market, with actual sales commencing once PainChek receives FDA De Novo clearance for the PainChek Adult App.
This agreement with Eldermark is a key milestone as PainChek expands its presence in the US market in anticipation of FDA clearance. The partnership aims to bring PainChek's technology to a broader audience and further support best-practice pain management in the US long-term care sector.